Report of Foreign Issuer (6-k)
24 August 2019 - 1:57AM
Edgar (US Regulatory)
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16
of the Securities Exchange Act of 1934
For the month of August 2019
Commission File Number 001-37410
ESSA Pharma Inc.
(Translation of registrant’s name into
English)
Suite 720, 999 West Broadway, Vancouver,
British Columbia, Canada, V5Z 1K5
(Address of principal executive offices)
Indicate by check mark whether the registrant
files or will file annual reports under cover of Form 20-F or Form 40-F:
Form 20-F x
Form 40-F ¨
Indicate by check mark if the registrant
is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ¨
Indicate by check mark if the registrant
is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ¨
EXHIBITS INCLUDED AS PART OF THIS REPORT
SIGNATURES
Pursuant to the requirements of the
Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto
duly authorized.
|
|
|
|
|
|
|
|
|
ESSA
PHARMA INC.
|
|
|
(Registrant)
|
|
|
|
Date: August 23, 2019
|
|
By:
|
|
/S/
DAVID WOOD
|
|
|
Name:
Title:
|
|
David Wood
Chief Financial Officer
|
ESSA Pharma (NASDAQ:EPIX)
Historical Stock Chart
From Apr 2024 to May 2024
ESSA Pharma (NASDAQ:EPIX)
Historical Stock Chart
From May 2023 to May 2024